Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of UDP-glucose as a Urinary Biomarker for Early Detection of Cardiac Surgery-associated Pediatric Acute Kidney Injury

NCT03263325 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT03263325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03263325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of UDP-glucose as a Urinary Biomarker for Early Detection of Cardiac Surgery-associated Pediatric Acute Kidney Injury
Lead sponsor
Boston Children's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
October 25, 2017
Completion date
February 1, 2027
Enrollment
305 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury